Meadow Creek Investment Management’s Novo Nordisk NVO Stock Holding History

Meadow Creek Investment Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-34,952	Closed	-$824K	–	1361
2018 Q3	$824K	Hold	34,952	–	–	0.02%	526
2018 Q2	$806K	Hold	34,952	–	–	0.02%	496
2018 Q1	$861K	Hold	34,952	–	–	0.02%	466
2017 Q4	$938K	Hold	34,952	–	–	0.02%	465
2017 Q3	$841K	Hold	34,952	–	–	0.02%	458
2017 Q2	$750K	Hold	34,952	–	–	0.02%	480
2017 Q1	$599K	Hold	34,952	–	–	0.01%	510
2016 Q4	$627K	Buy	+34,952	New	+$634K	0.02%	462

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Meadow Creek Investment Management's NVO Position: Q4 2018 in Review

Meadow Creek Investment Management sold out of Novo Nordisk (NVO) in Q4 2018, closing a stake of 34,952 shares — an estimated $824K sold.

Meadow Creek Investment Management first reported a position in NVO in Q4 2016 and held it in 8 quarters. The position peaked at $938K in Q4 2017. 550 funds tracked by Wall St. Rank hold NVO as of Q4 2018.

Meadow Creek Investment Management reported no remaining Novo Nordisk position as of Q4 2018 after selling out during the quarter.
Meadow Creek Investment Management sold 34,952 Novo Nordisk shares in Q4 2018, an estimated $824K.
Meadow Creek Investment Management first reported a position in Novo Nordisk in Q4 2016 and held it in 8 quarters.
Meadow Creek Investment Management's Novo Nordisk position peaked at $938K in Q4 2017.
550 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2018.

Based on Meadow Creek Investment Management's 13F filing for Q4 2018, filed 13 Feb 2019.